DBV Technologies, a biopharmaceutical company focused on food allergy treatments, will announce its third quarter 2026 financial results and provide a business update on October 28, 2026. The company will hold a conference call and webcast at 5:00 p.m. ET to discuss the results. DBV Technologies is developing the VIASKIN® Patch, a non-invasive treatment for food allergies, currently in clinical trials for peanut allergies in young children. This update is important for investors tracking progress in innovative allergy treatments and the company's financial health.
DBV Technologies shares news on Q3 2026 results and business updates. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 03:11 WIB: 88 of 150 health stocks rose, 62 fell. Notable movers include SLS at USD 12.15 (+7.14%), TXG at USD 78.05 (+6.98%) with 82% sell orders, and CLPT at USD 9.67 (+6.97%) with 100% buy orders.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
TOP Ships Inc. will implement a 1-for-10 reverse stock split of its common shares effective November 6, 2026, reducing the number of shares outstanding by a factor of ten without changing the company's market capitalization or shareholder ownership p...
XRP cannot be ISO 20022 compliant because the standard only defines the format of payment messages between banks, not the means of payment like coins or tokens. The migration to ISO 20022 for cross-border payments via Swift was completed in November ...
Bitcoin's 90-day correlation with gold rose to 54%, the strongest since 2014, while its correlation with the Nasdaq-100 dropped to 33%, near a one-year low. This shift coincided with gold's 7% decline over the past month and a weakening U.S. dollar s...
On October 28, chart analysis identified key support and resistance levels for several cryptocurrencies. Zcash (ZEC) showed resistance near $1,300 and support around $1,195 and $1,050. XRP's resistance was noted at $1.37 with support between $1.25 an...
